TopNewsOn
Business

Summit Therapeutics’ stock tumbles again as FDA recommends new trial for lung-cancer drug

Jaimy Lee·MarketWatch·November 17, 2026

The U.S. regulator’s disclosure was more extensive than what the biotech company had announced Sunday.

Read the full story at MarketWatch →